Business
Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference
Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference ...
About this update from Bausch Health Companies Inc.
[{"type":"text","content":"\n \n \n \n Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:black 0pt; BORDER-RIGHT:black 0pt; BORDER-BOTTOM:black 0pt; PADDING-LEFT:0.50em; BORDER-LEFT:black 0pt; PADDING-RIGHT:0.50em\n}\n.prnbcc{\nBORDER-TOP-COLOR:; BORDER-COLLAPSE: COLLAPSE; BORDER-LEFT-COLOR:; BORDER-BOTTOM-COLOR:; BORDER-RIGHT-COLOR:\n}\n \n \n \n \n \n \n PR Newswire\n \n \n \n \n \n Eight Poster Presentations Include New Analyses of\n \n \n ARAZLO\n \n ®\n \n ,\n \n \n \n \n DUOBRII\n \n ®\n \n and SILIQ\n \n ®\n \n \n \n \n \n LAVAL, QC\n \n ,\n \n Oct. 19, 2021\n \n /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the presentation of eight posters during the Fall Clinical Dermatology Conference, which takes place\n \n Oct. 21-24, 2021\n \n . The presentations will feature new efficacy and safety analyses of ARAZLO\n \n ®\n \n (tazarotene) Lotion, 0.045%, long-term outcomes of DUOBRII\n \n ®\n \n (halobetasol propionate and tazarotene) Lotion 0.01%/0.045%, quality of life improvement with SILIQ\n \n ®\n \n (brodalumab) injection 210 mg/1.5 ml and new onychomycosis treatment recommendations. Please see below for warning about suicidal ideation and behavior with SILIQ. The company will also host two educational events on ARAZLO\n \n ®\n \n and DUOBRII\n \n ®\n \n .\n \n \n The complete list of poster presentations that will include Ortho Dermatologics products, as well as the list of featured events is as follows:\n \n \n \n Scientific Posters\n \n \n \n \n ARAZLO\n \n ®\n \n (tazarotene) Lotion, 0.045%\n \n \n \n \n \n \"Efficacy and Safety of Tazarotene 0.045% Lotion in White Adults with Moderate-to-Severe Acne.\"\n \n \n Del Rosso\n \n et al.\n \n \n \n \"Tazarotene 0.045% Lotion for Acne: Formulation, Application Characteristics, and Clinical Efficacy and Safety.\"\n \n Draelos et al.\n \n \n \...